Skip to main content
Signal8

Dennewill James Robert Jr.

SEC insider (Form 3/4/5 filer). CIK 0002106895. Chief Operating Officer at SpyGlass Pharma, Inc. (SGP). 1 reported Form 4/5 transaction since Sep 2024; latest on Feb 5, 2026. Located in ALISO VIEJO, CA.

Companies Dennewill James Robert Jr. has filed insider reports for

  • SpyGlass Pharma, Inc. (SGP): Officer, Chief Operating Officer
Dennewill James Robert Jr. profile photo

Dennewill James Robert Jr.

CIK: 0002106895

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

SpyGlass Pharma, Inc. logo
SGP

SpyGlass Pharma, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (1 total)

  • SpyGlass Pharma, Inc. logo
    SGP

    SpyGlass Pharma, Inc.

    Feb 5, 2026
    Award

    Stock Option (right to buy)

    Direct
    105K shares-

1-1 of 1